Interestingly, the differentiation of cMSCs into adipocytes, significantly defective in patients with IH at T0, was improved in patients receiving therapy for 9–12 months, as suggested by the up-regulated levels of both PPARγ and C/EBPα. Here, PPARG is linked to isolated hemihyperplasia.